Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$33.83−0.35 (-1.02%)
Close on Nov 12, 2026Market cap $2.21BP/E –Yield –
Pharvaris enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pharvaris's enterprise value was $1.67B on Nov 11, 2026, against $1.30B a year earlier. Over the last 5 years it ranged from -$152.04M to $1.71B, with a median of $452.93M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.67B | +31.8% |
| 2025 | Dec 31, 2025 | $1.26B | +232.6% |
| 2024 | Dec 31, 2024 | $380.33M | -48.9% |
| 2023 | Dec 29, 2023 | $743.87M | +487.1% |
| 2022 | Dec 30, 2022 | $126.69M | – |
| 2021 | Dec 31, 2021 | -$41.84M | – |
See a number that looks wrong?